Back to search
FDAFDA · Food and drugs·Recall number D-0749-2023

vasopressin 50 units added to 0.9% sodium chloride 50 mL*, 1 unit/mL*, 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-9002-1.

Published May 31, 2023 · Recall initiated: April 28, 2023

Summary

FDA records drug Class II recall D-0749-2023, published May 31, 2023 and initiated April 28, 2023. Recalling firm: Central Admixture Pharmacy Services, Inc.; Status: Terminated; Reported quantity: 4259 bags; Lot: Lot # 37-883209, 37-883211, 37-883212, 37-883214, 37-883215, Exp 04/30/2023; 37-883776, Exp 05/02/2023; 37-884451, Exp 05/04/2023; 37-884805, 37-884806, 37-884808, 37-884810, 37-884811, Exp 05/07/2023; 37-886498, 37-886506, 37-886507, 37-886509, 37-886511, 37-886512, Exp 05/14/2023; 37-887319, 37-887321, Exp 05/16/2023; 37-889572, 37-889574, Exp 05/24/2023; 37-890881, 37-890883, 37-890884, 37-890887, Exp 05/30/2023; 37-892003, 37-892004, 37-892006, Exp 06/05/2023; 37-893157, Exp 06/08/2023; 37-893460, 37-893461, 37-893463, Exp 06/11/2023; 37-894619, 37-894648, 37-894650, Exp 06/14/2023; 37-895213, 37-895216, 37-895219, 37-895223, 37-895225, Exp 06/18/2023; 37-896813, Exp 06/22/2023; 37-897069, 37-897074, Exp 06/25/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Central Admixture Pharmacy Services, Inc.
Distributor
Nationwide in the USA.
Lot
Lot # 37-883209, 37-883211, 37-883212, 37-883214, 37-883215, Exp 04/30/2023; 37-883776, Exp 05/02/2023; 37-884451, Exp 05/04/2023; 37-884805, 37-884806, 37-884808, 37-884810, 37-884811, Exp 05/07/2023; 37-886498, 37-886506, 37-886507, 37-886509, 37-886511, 37-886512, Exp 05/14/2023; 37-887319, 37-887321, Exp 05/16/2023; 37-889572, 37-889574, Exp 05/24/2023; 37-890881, 37-890883, 37-890884, 37-890887, Exp 05/30/2023; 37-892003, 37-892004, 37-892006, Exp 06/05/2023; 37-893157, Exp 06/08/2023; 37-893460, 37-893461, 37-893463, Exp 06/11/2023; 37-894619, 37-894648, 37-894650, Exp 06/14/2023; 37-895213, 37-895216, 37-895219, 37-895223, 37-895225, Exp 06/18/2023; 37-896813, Exp 06/22/2023; 37-897069, 37-897074, Exp 06/25/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was vasopressin 50 units added to 0.9% sodium chloride 50 mL*, 1 unit/mL*, 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-9002-1. recalled?

Yes. FDA published recall D-0749-2023 on May 31, 2023. Reported hazard: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail